01:53 PM EDT, 03/20/2024 (MT Newswires) -- Lifecore Biomedical ( LFCR ) said Wednesday it has decided to continue with its standalone strategic plan after evaluating various alternatives, including reviewing more than 75 potential buyers.

The company also named Paul Josephs its next president and chief executive officer, effective May 20.

Shares slumped 32%, with intraday trading volume at over 2.21 million versus a daily average of about 124,000.

Aquestive Therapeutics ( AQST ) shares slumped 16% amid heavy trading after the company priced an underwritten public offering of about 16.7 million common shares at $4.50 per share, targeting gross proceeds of about $75 million.

More than 6.5 million shares traded intraday compared with a daily average of about 1.67 million.

Harrow Health's (HROW) shares sank after the company swung to a Q4 core net loss, while sales jumped.

Shares dropped 3%, with intraday trading volume at over 1.92 million compared with a daily average of about 357,000.

Price: 4.91, Change: -2.28, Percent Change: -31.78